NYKODE THERAPEUTICS ASA: årsregnskap 2021 vs 2020
Shrank 83% on revenue, slipped into loss, cash halved-plus
approved 2022-03-31; registry 2022-09-05; journal 2022 915124
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for NYKODE THERAPEUTICS ASA. Revenue 215.69m NOK → 35.77m NOK (-83.4%). Net result +149.77m NOK → -8.60m NOK. Equity 178.85m NOK → 194.9k NOK.
On the constructive side: owners injected capital; payroll decreased. Pressures included: revenue fell; operating result weakened; fell into a net loss.
Also worth watching: sharp cash drawdown; book investments changed. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.
At a glance
Scorecard
What improved
-
↑
Owners injected capital
Paid-in equity rose 65.09m NOK → 89.71m NOK (+24.61m NOK). Reported fact
-
↑
Payroll decreased
Salary cost 16.05m NOK → 14.46m NOK (7% → 40% of revenue). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 215.69m NOK to 35.77m NOK (-83.4% YoY). Calculated
-
↓
Operating result weakened
Operating result +178.26m NOK → -9.92m NOK (op. margin 82.6% → -27.7%). Calculated
-
↓
Fell into a net loss
Net result flipped from 149.77m NOK profit to a loss of 8.60m NOK. Calculated
-
↓
Equity eroded
Book equity 178.85m NOK → 194.9k NOK (equity ratio 77.8% → 73.3%). Calculated
-
↓
Cash fell
Bank deposits 183.85m NOK → 214.7k NOK (-99.9% YoY). Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (183.85m NOK → 214.7k NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Book investments changed
Investment / intangible book value 556.0k NOK → 941.0k NOK. Reported fact